FLJ37396: A Transmembrane Protein for Targeted Therapies (G100996634)

Target Name: Transmembrane protein FLJ37396

NCBI ID: G100996634

Other Name(s): LOC100996634

FLJ37396: A Transmembrane Protein for Targeted Therapies

FLJ37396, a member of the Kinesin-67 family, is a transmembrane protein that has been identified as a potential drug target and biomarker. This protein plays a crucial role in the regulation of cell signaling pathways, including the T-cell receptor signaling pathway. FLJ37396 has been shown to interact with multiple intracellular signaling molecules, including T-cell receptor tyrosine kinase (TK), leading to the regulation of immune cell function and cell survival.

The T-cell receptor signaling pathway is a critical pathway involved in the regulation of immune cell function and the generation of diverse immune responses. T-cells are a crucial source of immunity against infections and cancer, and their regulation by FLJ37396 is critical for the development and maintenance of a healthy immune system.

FLJ37396 is a protein that has been shown to interact with multiple intracellular signaling molecules, including T-cell receptor tyrosine kinase (TK). This interaction between FLJ37396 and TK leads to the regulation of T-cell cell function and cell survival.

The Importance of FLJ37396

The regulation of T-cell cell function by FLJ37396 is critical for the development and maintenance of a healthy immune system. T-cells are a crucial source of immunity against infections and cancer, and their regulation by FLJ37396 is critical for the development and maintenance of a healthy immune system.

FLJ37396 plays a crucial role in the regulation of the T-cell receptor signaling pathway. This protein has been shown to interact with multiple intracellular signaling molecules, including T-cell receptor tyrosine kinase (TK). This interaction between FLJ37396 and TK leads to the regulation of T-cell cell function and cell survival.

The T-cell receptor signaling pathway is a critical pathway involved in the regulation of immune cell function and the generation of diverse immune responses. This pathway is critical for the development and maintenance of a healthy immune system, and FLJ37396 plays a crucial role in this process.

Drug Targeting and Biomarker

FLJ37396 has the potential to be a drug target for the treatment of various diseases, including cancer and autoimmune disorders. The regulation of T-cell cell function by FLJ37396 makes it an attractive target for the development of anti-cancer and anti-inflammatory drugs.

FLJ37396 has also been shown to be a potential biomarker for the diagnosis and prognosis of cancer. The regulation of T-cell cell function by FLJ37396 is critical for the development and maintenance of a healthy immune system, which is a crucial factor in the regulation of cancer progression.

Conclusion

FLJ37396 is a transmembrane protein that has been shown to interact with multiple intracellular signaling molecules, including T-cell receptor tyrosine kinase (TK). This interaction between FLJ37396 and TK leads to the regulation of T-cell cell function and cell survival. With its potential as a drug target and biomarker, FLJ37396 is an attractive target for the development of anti-cancer and anti-inflammatory drugs.

Protein Name: Transmembrane Protein FLJ37396

More Common Targets